Abstract
Results of our meta-analysis suggest that dynamic contrast-enhanced MR imaging has excellent specificity and moderate, although highly variable, sensitivity in the detection of small hepatocellular carcinoma that measures up to 2 cm. PurposeTo determine the performance of dynamic contrast material–enhanced magnetic resonance (MR) imaging in the diagnosis of small (≤2-cm) hepatocellular carcinoma (HCC) and to identify factors that influence this performance.Materials and MethodsMedline and Embase databases were searched for studies performed from January 2000 to March 2014 in which the performance of MR imaging was reported for the detection of HCC up to 2 cm on either a lesion- or patient-based level, with sufficient data to construct 2 × 2 contingency tables. Diagnostic performance was quantitatively pooled for all studies by using a bivariate random-effects model with exploration involving subgroup analysis, meta-regression, and determination of study heterogeneity.ResultsTwenty-two studies with 1387 small HCC lesions in 1908 patients met inclusion criteria. Heterogeneity was higher for sensitivity (range, 30%–99%) than specificity (range, 61%–100%). Overall sensitivity was 78% (95% confidence interval [CI]: 68%, 85%; I2 = 89%), and...

This publication has 53 references indexed in Scilit: